论文信息 - Phase 1 and preclinical profiling of ESM‐HDAC391, a myeloid‐targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia - 字舞流文

Phase 1 and preclinical profiling of ESM‐HDAC391, a myeloid‐targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia

R. Prinjha | H. Lewis | M. Toal | Faiz Ahmad | R. Davis | J. Molnár | A. Bassil | C. Sharp | Yvette M Henry | N. Maller | David R Tough | Rebecca C. Furze | Nigel Parr | D. Howe | Rajendra P. Singh | Sharon G Bernard | Adele Gibson | Rob P Davis | A. Gibson | Catriona Sharp | Claire Maller